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Abstract: An ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS)
method, in combination with a mixed matrix membrane microextraction method for the quantification
of nonsteroidal anti-inflammatory drugs (NSAIDs) in environmental water samples, is reported.
The extraction device was prepared by casting well-dispersed polymeric bonded octadecyl (C18)
particles in a cellulose triacetate matrix solution onto commercially available 200 µL micropipette tips.
The membrane formed contains 25% of the adsorbent loading amount and was firmly attached to
the inner wall of the membrane tip. The dynamic extraction was performed by withdrawing and
dispensing the sample solution through the tip device for effective analyte adsorption, followed by
the analyte desorption process into 40 µL of methanol and acetonitrile (1:1) prior to UPLC–MS/MS
analysis. NSAIDs—namely diclofenac, ibuprofen, indoprofen, naproxen and sulindac—were chosen
as targeted analytes. Several extraction parameters were comprehensively optimized, including
sample pH value, ionic strength, dynamic extraction cycle, desorption solvent and desorption time.
The optimized conditions demonstrated a linear range from 0.25 to 500 ng L−1, with correlation
coefficients (r2) from 0.9988 to 0.9992 and detection limits ranging from 0.08 to 0.40 ng L−1. The
recoveries of the spiked water samples were between 92% and 99% and exhibited excellent precision
relative to standard deviations (RSDs ≤ 4.9%), and enrichment factors (EFs) were at 201–249 for the
developed approach.
Keywords: microextraction; mixed matrix membrane; sample preparation; NSAIDs; UPLC–MS/MS
1. Introduction
The sample preparation method is commonly employed for the isolation of potential interference
in the sample and, at the same time, enriches the targeted analyte at the ultra-trace level to achieve
the detection limits. Although classical extraction methods such as liquid–liquid extraction (LLE)
and solid phase extraction (SPE) are particularly preferred, the drawbacks often stated are the high
running cost, high consumption of organic solvents and multistep separation techniques. In recent
years, a range of advanced miniaturized solid–liquid extraction methods—such as solid phase
microextraction (SPME) [1–3], micro-solid phase extraction (µ-SPE) [4,5], solid phase membrane tip
extraction (SPMTE) [6,7], stir bar sorptive extraction (SBSE) [8], thin film microextraction (TFME) [9,10]
and microextraction by packed sorbent (MEPS) [11]—have been proposed to reduce time as well as
errors, leading to low consumption of the hazardous solvent and low cost.
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One interesting method termed mixed matrix membrane microextraction [12–14], which is a
simple adsorb/desorb extraction method consisting of the adsorbent being incorporated into the
polymer matrix, was reported. The microextraction method was evaluated by dipping a small piece
of C18-MMM (7 × 7 mm) in a stirred 10 mL sample solution, followed by a desorption process into
100 µL of methanol prior to instrumental analysis. The membrane showed a high affinity for NSAIDs
in different spiked water samples, with enrichment factors (EFs) from 79 to 82, relative recoveries
ranging from 84% to 104%, and RSDs between 0.2% and 8.6% (n = 9). Moreover, single-layer graphene
(SLG), multiwall carbon nanotubes (MWCNTs) and polymeric bonded octadecyl (C18) particles are
examples of adsorbents that have successfully immobilized within the extraction membrane device
to monitor the ultra-trace level of priority organic pollutants and pharmaceuticals in environmental
waters [12,13]. This approach was proven to be a simplified experimental setup with low costs. Other
variations of extraction based on a mixed matrix membrane were also reported with satisfactory
practicability [15–17].
Recently, the contamination of pharmaceuticals in the environment has become a critical
issue in environmental chemistry. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a group
of pharmaceuticals drugs that have been widely used to treat pain, fever and anti-inflammation [18,19].
However, the contamination level of these drugs in the environmental ecosystem has now reached
alarming stages because of their continuous release into the environment. Diclofenac, together with 17
alpha-ethinylestradiol (EE2) and 17 beta-estradiol (E2), was included in the watch list of substances to
monitor in the field of water policy in Europe [18,20]. Miniaturized membrane-based microextraction
techniques have been proposed for the extraction of NSAIDs and organic pollutants from various
matrices. For instance, hollow-fiber liquid-phase microextraction (HF-LPME) [21], electromembrane
extraction (EME) [22–25] and SPME [26] are proven to be beneficial in minimizing organic solvent
usage. Nevertheless, analyzing the trace organic compound remains complex in complicated matrices
and a wide range of chemical properties of the analytes, and they can be at concentrations as low as
pg/mL in range [27,28].
Herein, we demonstrate a mixed matrix membrane microextraction approach coupled with
ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) for the
quantification of NSAIDs in water samples. For the first time, a mixed matrix membrane immobilized
with a C18 adsorbent was firmly cast within the inner wall of a commercial 200 µL micropipette
tip. In addition, the proposed extraction procedures were performed dynamically by introducing
the sample into the membrane tip for effective adsorption, followed by desorbing the analytes into
microliters of organic solvent prior to instrumental analysis. This concept is entirely new, relative to the
previous planar sheet membrane design, and the extraction was performed in stagnant condition [12,13].
As model analytes, NSAIDs—namely indoprofen, sulindac, naproxen, diclofenac and ibuprofen—were
used to compare with previous studies on the mixed matrix membrane extraction method performed
by our research groups [12]. The potential of the developed extraction method extracting the target
NSAIDs was investigated, optimized, validated and applied to real water samples.
2. Materials and Methods
Cellulose triacetate (CTA), potassium dihydrogen phosphate (KH2PO4), sodium chloride (NaCl),
sodium hydroxide (NaOH), sulindac, indoprofen, naproxen, diclofenac and ibuprofen were obtained
from Aldrich (Buchs, Switzerland). Organic solvents (HPLC grade) namely acetonitrile (MeCN),
methanol (MeOH), 2-propanol (2-PrOH) and toluene—were purchased from Merck (Darmstardt,
Germany). Deionized (DI) water was produced on a Direct-Q3 ultrapure water system (Merck Millipore,
Darmstadt, Germany) and used throughout the experiment. Other reagents and chemicals were
analytical grade and used without any further purification.
Stock solutions of NSAIDs (diclofenac, ibuprofen, indoprofen, naproxen and sulindac) at a
concentration of 100 µg mL−1 were dissolved using C-grade methanol and kept in a refrigerator.
Standard solutions at concentrations of 100 ng L−1 were prepared daily by diluting the stock solutions
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with DI water. In this work, the water samples were taken from the outlet of an effluent treatment
plant of the Universiti Teknologi Malaysia (UTM) Health Center in Skudai Johor, Malaysia. A 0.2 µm
polytetrafluoroethylene (PFTE) membrane filter (Macherey–Nagel GmbH, Germany) was used to
vacuum-filter the samples. For further use, the samples were stored at 4 ◦C in amber glass bottles
capped with Teflon-lined caps for no longer than a month. A blank analysis of wastewater performed
by conventional SPE polymeric bonded octadecyl (C18) cartridges [12] using UPLC–MS/MS showed
that the NSAIDs were free of contamination. Thus, the collected water samples were used to evaluate
the analytical performance of the extraction method. The standard and spiked sample solutions were
adjusted to pH 3.5 using 1 M HCl prior to extraction.
Asymmetrical C18 particles with an average size of 50 µm and a surface area of 480 m2 g−1 were
obtained from Macherey–Nagel (Düren, Germany). To prepare the mixed matrix membrane casting
solution, 10 mg of the C18 particles and 40 mg of CTA were dissolved in 1 mL of dichloromethane (DCM)
(equal to 25% w/w loading of C18). The casting solution was ultrasonicated for 5 min to achieve uniform
dispersion. Next, 100 µL of the casting solution was withdrawn into a 200 µL pipette tip (Eppendorf,
Hamburg, Germany) using a digital micropipette (Eppendorf, Hamburg, Germany). The end of the tip
was covered firmly with Parafilm (Bemis, Neenah, WI, USA) to avoid the casting solution from spilling.
The pipette tip was subsequently removed from the micropipette and placed in the pipette tip holder,
and the solution was then solidified by evaporation in an oven with a temperature maintained at 35 ◦C
for approximately 30 min. It was then removed from the pipette tip, and the membrane thickness was
determined using digital micrometers (MDC-1, Mitutoyo Corporation, Kawasaki, Japan). The average
thickness was approximately 50 µm.
The membrane tip was employed as the extraction device (Figure 1). The upper part of the
fabricated membrane tip (~7 mm in length) was cut off and firmly attached to a 10 mL disposable plastic
syringe (Terumo, Leuven, Belgium). The membrane tip was immersed in methanol for conditioning
for about 30 min to activate the sorbent surface, followed by rinsing with DI water. The sequence
of dynamic extraction begins by withdrawing the sample solution into the syringe device, followed
by dispensing the desorption solvent to collect the desorption extract (Figure 2). The procedure
starts with introducing 10 mL of the sample solution through the membrane tip device by pulling
the syringe plunger consistently at a constant flow rate of approximately 300 µL s−1 for an effective
analyte adsorption process on the sample/membrane interface. The withdrawn sample was dispensed
from the syringe, with a residence time of about 3 s, through the membrane tip back into the sample
vial for the second adsorption process at the same sample flowing speed. These dynamic extraction
procedures were repeated ten times to achieve optimum adsorption efficiency, followed by the washing
out the membrane tip wall lightly with DI water twice to remove any possible surface contamination.
Following the adsorption and washing process, the membrane tip was removed from the syringe and
reattached to a 1 mL plastic syringe (Terumo, Leuven, Belgium). The back extraction of NSAIDs from
the membrane tip was performed by flushing the membrane tip wall with 40 µL of methanol and
acetonitrile (1:1) as a desorption solvent repetitively for ten cycles. Finally, an enriched extract of 5.0 µL
was injected into the UPLC–MS/MS system for separation and detection.
The UPLC–ESI–MS/MS system consists of a Waters Acquity UPLC H-class system and a Xevo
TQ-S micro ESI mass spectrometer (Milford, MA, USA) controlled using MassLynx software (V4.1,
Waters Inc., Milford, MA, USA). The chromatographic separations were carried out on the Waters
UPLC BEH C18 1.7 µm (2.1 mm × 100 mm) column. The chromatographic parameters were maintained
at a column temperature of 40 ◦C, with a flow rate of 0.3 mL min−1 and an injection volume of 5 µL.
The binary mobile phase consists of 10 mM ammonium acetate (A) at 100% MeOH (B), and the NSAIDs
were separated using a gradient elution method consisting of 40% B at 0 min, 50% B at 2 min and 70%
B at 5 min. A multiple reaction monitoring (MRM) method was established via syringe infusion of
five NSAIDs to determine the MRM transitions. The MS parameters were as follows: MRM modes
(ESI +/−), capillary voltage, 1.0/−3.0 kV; cone voltage, 20 V; source temperature, 150 ◦C; desolvation
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temperature, 450 ◦C; and desolvation gas flow rate, 800 L h−1, respectively. Finalised MRM transitions
employed are illustrated in Table 1.
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Figure 2. Expanded view of dynamic microextraction. (a) The sample solution (SS) is continuously
withdrawn into the membrane tip for analyte adsorption. (b) The withdrawn SS is dispensed from the
membrane tip into the sample vial, with the analytes retained in the membrane phase (MP). (c) The
desorption solvent (DS) is continuously flushed in the membrane tip ten times, and the analytes are
transferred rapidly from the MP to the DS.
Table 1. Finalized multiple reaction monitoring (MRM) transition by ultra-performance liquid
chromatography–tandem mass spectrometry (UPLC–MS/MS) electrospray ionization polarity switch.
Analyte Ret nti nTi e (min) Polarity Precursor Ion Product Ion 1 Product Ion 2
Indoprofen 1.49 Positive 282.2 77 236.1
Sulindac 1.62 Positive 357.1 233.1 341.1
Naproxen 1.74 Positive 231.1 170 185.1
Diclofenac 2.40 Positive 296.1 215 250
Ibuprofen 2.55 Negative 205 161.1 172.9
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3. Results and Discussion
3.1. Extraction Device Characterization
The membrane composition employed in this work was directly adopted from our earlier
research [12], and the extraction tip device preparation protocol was stated in Section 2. Representative
surfaces and cross-sectional scanning electron microscope (SEM) images for the membrane tip device
were obtained using a Hitachi SU-8020 field-emission SEM (Hitachi-Hitech, Tokyo, Japan) (Figure 3).
Overall, the membrane was attached firmly, surrounding the pipette tip wall with a measured
inner upper- and lower-end diameter of approximately 3 and 1 mm, respectively (Figure 3a). The
membrane’s mechanical structure was investigated by detaching the membrane from the tip wall prior
to characterization. As illustrated in Figure 3b, the membrane filled with C18 particles has a dense
structure. The cross-sectional image also clearly displays the tight and uniform distribution of C18
particles. Therefore, these favorable structures are highly suitable for the proposed microextraction
procedure. Furthermore, the dense structure observed on the upper surface also indicates that the high
sponginess of a pure CTA polymer matrix has disappeared [29] and is substituted by C18 particles
(Figure 3c). The inner membrane surface demonstrated an even and nonporous structure, and all the
components were well combined to form a homogeneous membrane surface (Figure 3d).
Separations 2020, 7, x FOR PEER REVIEW 5 of 10 
 
Table 1. Finalized multiple reaction monitoring (MRM) transition by ultra-performance liquid 











Indoprofen 1.49 Positive 282.2 77 236.1 
Sulindac 1.62 Positive 357.1 233.1 341.1 
Naproxen 1.74 Positive 231.1 170 185.1 
Diclofenac 2.40 Positive 296.1 215 250 
Ibuprofen 2.55 Negative 205 161.1 172.9 
3. Results and Discussion 
3.1. Extraction Device Characterization 
The membrane composition employed in this work was directly adopted from our earlier 
research [12], and the extraction tip device preparation protocol was stated in Section 2. 
Representative surfaces and cross-sectional scanning electron microscope (SEM) images for the 
membrane tip device were obtained using a Hitachi SU-8020 field-emission SEM (Hitachi-Hitech, 
Tokyo, Japan) (Figure 3). Overall, the membrane was attached firmly, surrounding the pipette tip 
wall with a easured inner upper- and lower-end diameter of approximately 3 and 1 mm, 
respectively (Figure 3a). The me brane’s mechanical structure was investigated by detaching the 
e brane from the tip wall prior to characterization. As illustrated in Figure 3b, the membrane 
filled with C18 particles has a dense structure. The cross-sectional image also clearly displays the 
tight and uniform distribution of C18 particles. Therefore, these favorable structures are highly 
suitable for the proposed microextraction procedure. Furthermore, the dense structure observed on 
the upper surface also indicates that the high sponginess of a pure CTA polymer matrix has 
disappeared [29] and is substituted by C18 particles (Figure 3c). The inner membrane surface 
demonstrated an even and nonporous structure, and all the components were well combined to 
for  a homogeneous me brane surface (Figure 3d). 
 
Figure 3. Field-emission SEM images of the C18-mixed matrix membrane tip device: (a) overall tip 
structure (top view); (b) cross-section image of membrane; (c) outer surface image of membrane; (d) 
inner surface image of membrane. 
3.2. Optimization of Extraction Conditions 
The operational parameters were elucidated with respect to the pH of the sample, ionic 
strength, dynamic extraction cycle, desorption solvent and desorption time to comprehensively 
study the performance of the protocol for mixed matrix membrane microextraction.  
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structure (top view); (b) cross-section image of embrane; (c) oute surface image of membrane;
(d) inner surface image of membrane.
3.2. Optimization of Extraction Conditions
The operational parameters were elucidated with respect to the pH of the sample, ionic strength,
dynamic extraction cycle, desorption solvent and desorption time to comprehensively study the
performance of the protocol for mixed matrix membrane microextraction.
As the targeted NSAID analytes are adsorbed by the membrane, mainly via hydrophobic
interaction, the pH of the sample solution should be maintained in the acidic medium to keep it in
the molecular state. The sample pH values of 2.5, 3.5, 4, 5 and 6 were studied by adjusting with 1 M
HCl (Figure S1). Peak areas gradually increased from 2.5 and reached their highest when a pH of 3.5
was adopted. Further increases in the sample pH to 4, 5 and 6 resulted in decreased peak areas as
the targeted analytes started to be deprotonated into their ionic forms at higher pH values [30–32].
A similar trend was observed in the previous work [12]. Hence, a sample pH of 3.5 was chosen for the
subsequent analyses.
Ionic strength was investigated as the addition of salt can decrease the solubility of analytes and,
therefore, enhance the salting-out effects [7]. Hence, NaCl was added to the final concentrations of 0%,
1%, 2%, 2.5%, 5%, 7.5% and 10% (w/v) (Figure S2). The peak areas were highest when 2% (w/v) of
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NaCl was added to the sample. However, adding more NaCl led to no improvement of extraction
performance, possibly because of the increased viscosity of the sample [33]. Therefore, the following
experiments were performed with the addition of 2% (w/v) NaCl into the sample solution.
The extraction performance in this proposed new approach can be significantly improved by
increasing the number of dynamic extraction cycles employed, which will directly increase the
interaction of NSAID analytes in the sample solution and membrane surface. However, the use of
excessively high numbers of extraction cycles will significantly prolong the total analysis time. Hence,
extraction cycles in the range of two, four, six, eight, ten, twelve, fourteen and sixteen cycles were
further optimized (Figure 4a). The peak areas were at their highest when ten extraction cycles were
performed, which took about 10 min, and reached a plateau when the cycles were increased to twelve,
fourteen and sixteen. Thus, ten extraction cycles were performed for subsequent analyses.
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Figure 4. Effect of extraction cycle (a) and desorption time (b) on peak responses using mixed matrix
membrane tip microextraction. Extraction pa ameters: sample H, 3.5; addition of salt, 2% (w/v);
sample volume, 10 mL; desorption solvent volume, 40 µL; analyte concentration, 100 ng L−1 of spiked
olution. (Error bars repr ent sta dard de iations of results, n = 3).
Organic solvents compatible to the mobile phase of LC–MS—namely methanol, ethanol,
2-prop nol, acetonitrile and a mixture of methanol and acetonitrile (1:1)—were evaluated as desorption
solvents to retrieve the entrapped analytes by the desorption process. The use of methanol and
acetonitrile (1:1) as desorption solvents generally exhibited the highest peak areas [30] among all the
solvents being investigated.
The desorption step was then further investigated by examining the desorption rinsing time of
2.5, 5, 7.5, 10, 12.5 and 15 min (Figure 4b). The peak areas gradually increased with the increasing
desorption time from 2.5 min onward, reached their highest at 10 min and reached a plateau when
the desorption rinsing time was extended to 12.5 and 15 min. Note that the volume of the desorption
solvent was set at 40 µL, as this is the lowest volume that can be used to rinse the entire membrane
wall using a 1 mL plastic syringe.
3.3. Evaluation of Analytical Performance
The optimum extraction conditions for the 10 mL sample solutions at a concentration of 10 ng L−1
were selected as follows: pH 3.5, 2.0% of salt addition, a 40 µL mixture of methanol and acetonitrile (1:1)
as the desorption solvent, and a desorption time of 10 min under ultrasonication. The analytical figures
of merit are summarized in Table 2. The calibration curves were plotted by the peak response of the
analytes versus the concentration, and each concentration was performed in triplicate. The calibration
plots of each analyte—prepared at 0.25–500 ng L−1 for indoprofen and diclofenac, 0.30–500 ng L−1
for sulindac, 0.50–500 ng L−1 for naproxen and 1.30–500 ng L−1 for ibuprofen—were observed to be
linear for spiked sewage water samples, with correlation coefficients (r2) ranging between 0.9988 and
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0.9992. The overall detection limits (LODs) and quantification limits (LOQs) were 0.08–0.40 ng L−1 and
0.25–1.30 ng L−1, respectively, with EFs of 201–249. The repeatability of the spiked concentration of
10 pg/mL was satisfactory, with an intraday (n = 5) RSD of 4.3–4.9%. This newly proposed approach
was compared with the previously reported method, as listed in Table S1, and was proven able to
provide superior detection sensitivity for trace-level analysis.
Table 2. Linear range, correlation coefficient (r2), detection limits (LODs), quantification limits (LOQs),
repeatability, and enrichment factors (EFs) of nonsteroidal anti-inflammatory drugs (NSAIDs) in spiked









RSD (%, n = 5) EF
4
Indoprofen 0.25–500 0.9992 0.08 0.25 4.3 202
Sulindac 0.30–500 0.9988 0.10 0.30 4.6 208
Naproxen 0.50–500 0.9990 0.15 0.50 4.5 201
Diclofenac 0.25–500 0.9989 0.08 0.25 4.3 241
Ibuprofen 1.30–500 0.9990 0.40 1.30 4.9 249
Calculated from S/N = 3 1 and S/N = 10 2; From peak areas at 2 ng L−1 (n = 5) of each NSAID using the same tip 3;
EF = the final concentration of analyte in the enriched extract/initial concentration of analyte in the sample solution 4.
Fifteen batches of spiked sewage water samples from the same source, containing 10 ng L−1 of
NSAIDs, were evaluated consecutively on the stability of the developed membrane tip microextraction
device under optimum conditions. The results of RSDs ≤ 5% (n = 10) proved that the membrane tip
has achieved good stability. However, the peak areas then gradually decreased, and a loss of extraction
efficiency of approximately 2–7% was shown for the eleventh and twelfth extraction compared to the
first extraction. Membrane tip-to-tip variation was also investigated with RSDs ≤ 8% (n = 8).
The water samples were spiked with NSAIDs at three concentration levels of 10, 100 and 500 ng L−1
under optimized conditions to evaluate the applicability and consistency of the developed method
in real water samples The recoveries were between 92% and 99% (n = 5) and with relative standard
deviations of 4.3–4.9%, proving that the extraction efficiencies were reliable and consistent as they were
unaffected by the background of the water matrices. Figure 5 showed the UPLC-MS/MS chromatogram
of NSAIDs separation when spiked in water sample after treatment with mixed matrix membrane tip
extraction under optimum parameters. The targeted analytes achieved upconcentration after extraction.Separations 2020, 7, x FOR PEER REVIEW 8 of 10 
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